{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T10:32:24Z","timestamp":1776853944758,"version":"3.51.2"},"reference-count":80,"publisher":"Bentham Science Publishers Ltd.","issue":"9","funder":[{"DOI":"10.13039\/501100004410","name":"Scientific and Technological Research Council of T\u00fcrkiye","doi-asserted-by":"publisher","award":["Project Number 118S580"],"award-info":[{"award-number":["Project Number 118S580"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["ACAMC"],"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:sec>\n<jats:title>Introduction:<\/jats:title>\n<jats:p>Carbonic anhydrases (CAs) are widespread metalloenzymes with the core function of\ncatalyzing the interconversion of CO2 and HCO3-. Targeting these enzymes using selective inhibitors has\nemerged as a promising approach for the development of novel therapeutic agents against multiple diseases.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>A series of novel thiosemicarbazones-containing derivatives were synthesized, characterized, and tested\nfor their inhibitory activity against pharmaceutically important human CA I (hCA I), II (hCA II), IX (hCA IX),\nand XII (hCA XII) using the single tail approach.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>The compounds generally inhibited the isoenzymes at low nanomolar concentrations, with compound 6b\nhaving Ki values of 7.16, 0.31, 92.5, and 375 nM against hCA I, II, IX and XII, respectively. Compound 6e exhibited\nKi values of 27.6, 0.34, 872, and 94.5 nM against hCA I, II, IX and XII, respectively.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>To rationalize the inhibition data, molecular docking studies were conducted, providing insight into\nthe binding mechanisms, molecular interactions, and selectivity of the compounds towards the isoenzymes.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0118715206290722240125112447","type":"journal-article","created":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T09:02:31Z","timestamp":1708074151000},"page":"649-667","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Thiosemicarbazone-benzenesulfonamide Derivatives as Human Carbonic Anhydrases\nInhibitors: Synthesis, Characterization, and <i>In silico<\/i> Studies"],"prefix":"10.2174","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0041-4612","authenticated-orcid":true,"given":"Muhammed","family":"Trawally","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Istanbul University, Istanbul, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9928-4733","authenticated-orcid":true,"given":"K\u00fcbra","family":"Demir-Yaz\u0131c\u0131","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Istanbul University, Istanbul, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1470-7192","authenticated-orcid":true,"given":"Andrea","family":"Angeli","sequence":"additional","affiliation":[{"name":"Department of NEUROFARBA, Section of Pharmaceutical and Nutraceutical Sciences, University of Florence, Florence, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5736-488X","authenticated-orcid":true,"given":"Kerem","family":"Kaya","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Istanbul Technical University, Istanbul, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8416-0471","authenticated-orcid":true,"given":"Atilla","family":"Akdemir","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Faculty of Pharmacy, Istinye University, Istanbul, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4262-0323","authenticated-orcid":true,"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[{"name":"Department of NEUROFARBA, Section of Pharmaceutical and Nutraceutical Sciences, University of Florence, Florence, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3680-1945","authenticated-orcid":true,"given":"\u00d6zlen","family":"G\u00fczel-Akdemir","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Istanbul University, Istanbul, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1080\/14756366.2021.1972995","volume":"36","author":"Nocentini A.","year":"2021","unstructured":"Nocentini A.; Supuran C.T.; Capasso C.; An overview on the recently discovered iota-carbonic anhydrases. J Enzyme Inhib Med Chem  2021,36(1),1988-1995","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"345","DOI":"10.3109\/14756366.2015.1122001","volume":"31","author":"Supuran C. T.","year":"2016","unstructured":"Supuran C. T.; How many carbonic anhydrase inhibition mechanisms exist_ _ Enhanced Reader \/\/ How many carbonic anhydrase inhibition mechanisms exist? J Enzyme Inhib Med Chem  2016,31(3),345-360","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1042\/BCJ20160115","volume":"473","author":"Supuran C.T.","year":"2016","unstructured":"Supuran C.T.; Structure and function of carbonic anhydrases. Biochem J  2016,473(14),2023-2032","journal-title":"Biochem J"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1080\/17460441.2017.1253677","volume":"12","author":"Supuran C.T.","year":"2017","unstructured":"Supuran C.T.; Advances in structure-based drug discovery of carbonic anhydrase inhibitors. Expert Opin Drug Discov  2017,12(1),61-88","journal-title":"Expert Opin Drug Discov"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-030-79511-5_1","volume":"75","author":"Chegwidden W.R.","year":"2021","unstructured":"Chegwidden W.R.; The carbonic anhydrases in health and disease. The Carbonic Anhydrases: Current and Emerging Therapeutic Targets  2021,75,1-12","journal-title":"The Carbonic Anhydrases: Current and Emerging Therapeutic Targets"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1016\/j.bmc.2012.04.044","volume":"21","author":"Imtaiyaz H M.","year":"2013","unstructured":"Imtaiyaz H M.; Shajee B.; Waheed A.; Ahmad F.; Sly W.S.; Structure, function and applications of carbonic anhydrase isozymes. Bioorg Med Chem  2013,21(6),1570-1582","journal-title":"Bioorg Med Chem"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/978-94-007-7359-2_8","author":"Aspatwar A.","year":"2014","unstructured":"Aspatwar A.; Tolvanen M.E.E.; Ortutay C.; Parkkila S.; Carbonic anhydrase related proteins: Molecular biology and evolution. Carbonic Anhydrase: Mechanism, Regulation, Links to Disease, and Industrial Applications  2014,135-156","journal-title":"Carbonic Anhydrase: Mechanism, Regulation, Links to Disease, and Industrial Applications"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3390\/metabo7030048","volume":"7","author":"Supuran C.T.","year":"2017","unstructured":"Supuran C.T.; Carbonic anhydrase inhibition and the management of hypoxic tumors. Metabolites  2017,7(3),48","journal-title":"Metabolites"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/B978-0-12-823974-2.00014-0","author":"Supuran C.T.","year":"2024","unstructured":"Supuran C.T.; Carbonic anhydrases. Metalloenzymes:From bench to bedside  2024,139-156","journal-title":"Metalloenzymes:From bench to bedside"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/nrd3554","volume":"10","author":"Neri D.","year":"2011","unstructured":"Neri D.; Supuran C.T.; Interfering with pH regulation in tumours as a therapeutic strategy. Nat Rev Drug Discov  2011,10(10),767-777","journal-title":"Nat Rev Drug Discov"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1042\/CS20210040","volume":"135","author":"Supuran C.T.","year":"2021","unstructured":"Supuran C.T.; Emerging role of carbonic anhydrase inhibitors. Clin Sci  2021,135(10),1233-1249","journal-title":"Clin Sci"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"4421","DOI":"10.1021\/cr200176r","volume":"112","author":"Alterio V.","year":"2012","unstructured":"Alterio V.; Di Fiore A.; D\u2019Ambrosio K.; Supuran C.T.; De Simone G.; Multiple binding modes of inhibitors to carbonic anhydrases: How to design specific drugs targeting 15 different isoforms? Chem Rev  2012,112(8),4421-4468","journal-title":"Chem Rev"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1002\/med.21713","volume":"40","author":"Mishra C.B.","year":"2020","unstructured":"Mishra C.B.; Tiwari M.; Supuran C.T.; Progress in the development of human carbonic anhydrase inhibitors and their pharmacological applications: Where are we today? Med Res Rev  2020,40(6),2485-2565","journal-title":"Med Res Rev"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1517\/13543776.2013.794788","volume":"23","author":"Masini E.","year":"2013","unstructured":"Masini E.; Carta F.; Scozzafava A.; Supuran C.T.; Antiglaucoma carbonic anhydrase inhibitors: A patent review. Expert Opin Ther Pat  2013,23(6),705-716","journal-title":"Expert Opin Ther Pat"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1517\/13543776.14.5.667","volume":"14","author":"Scozzafava A.","year":"2004","unstructured":"Scozzafava A.; Mastrolorenzo A.; Supuran C.T.; Modulation of carbonic anhydrase activity and its applications in therapy. Expert Opin Ther Pat  2004,14(5),667-702","journal-title":"Expert Opin Ther Pat"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/B978-0-444-63258-6.00010-X","author":"Ondriskova E.","year":"2015","unstructured":"Ondriskova E.; Debreova M.; Pastorekova S.; Tumor-associated carbonic anhydrases IX and XII. Carbonic anhydrases as biocatalysts: From theory to medical and industrial applications  2015,169-205","journal-title":"Carbonic anhydrases as biocatalysts: From theory to medical and industrial applications"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"e0207417","DOI":"10.1371\/journal.pone.0207417","volume":"13","author":"Mboge M.Y.","year":"2018","unstructured":"Mboge M.Y.; Chen Z.; Wolff A.; Mathias J.V.; Tu C.; Brown K.D.; Bozdag M.; Carta F.; Supuran C.T.; McKenna R.; Frost S.C.; Selective inhibition of carbonic anhydrase IX over carbonic anhydrase XII in breast cancer cells using benzene sulfonamides: Disconnect between activity and growth inhibition. PLoS One  2018,13(11),e0207417","journal-title":"PLoS One"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3390\/ijms23010461","volume":"23","author":"Giovannuzzi S.","year":"2021","unstructured":"Giovannuzzi S.; D\u2019Ambrosio M.; Luceri C.; Osman S.M.; Pallecchi M.; Bartolucci G.; Nocentini A.; Supuran C.T.; Aromatic sulfonamides including a sulfonic acid tail: New membrane impermeant carbonic anhydrase inhibitors for targeting selectively the cancer-associated isoforms. Int J Mol Sci  2021,23(1),461","journal-title":"Int J Mol Sci"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"114190","DOI":"10.1016\/j.ejmech.2022.114190","volume":"232","author":"Tawfik H.O.","year":"2022","unstructured":"Tawfik H.O.; Petreni A.; Supuran C.T.; El-Hamamsy M.H.; Discovery of new carbonic anhydrase IX inhibitors as anticancer agents by toning the hydrophobic and hydrophilic rims of the active site to encounter the dual-tail approach. Eur J Med Chem  2022,232,114190","journal-title":"Eur J Med Chem"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1080\/13543776.2022.2083502","volume":"32","author":"Nerella S.G.","year":"2022","unstructured":"Nerella S.G.; Singh P.; Arifuddin M.; Supuran C.T.; Anticancer carbonic anhydrase inhibitors: A patent and literature update 2018-2022. Expert Opin Ther Pat  2022,32(8),833-847","journal-title":"Expert Opin Ther Pat"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"3467","DOI":"10.1016\/j.bmcl.2010.05.009","volume":"20","author":"Supuran C.T.","year":"2010","unstructured":"Supuran C.T.; Carbonic anhydrase inhibitors. Bioorg Med Chem Lett  2010,20(12),3467-3474","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.4155\/fmc.14.68","volume":"6","author":"Carta F.","year":"2014","unstructured":"Carta F.; Supuran C.T.; Scozzafava A.; Sulfonamides and their isosters as carbonic anhydrase inhibitors. Future Med Chem  2014,6(10),1149-1165","journal-title":"Future Med Chem"},{"key":"ref=23","doi-asserted-by":"publisher","DOI":"10.36118\/pharmadvances.00.2019.06","volume":"1","author":"Supuran C.T.","year":"2019","unstructured":"Supuran C.T.; Mugelli A.; Polypharmacology of carbonic anhydrase inhibitors. Pharmadvances  2019,1(00)","journal-title":"Pharmadvances"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1007\/s00706-020-02664-9","volume":"151","author":"G\u00fczel-Akdemir \u00d6.","year":"2020","unstructured":"G\u00fczel-Akdemir \u00d6.; Trawally M.; \u00d6zbek-Babu\u00e7 M.; \u00d6zbek-\u00c7elik B.; Ermut G.; \u00d6zdemir H.; Synthesis and antibacterial activity of new hybrid derivatives of 5-sulfamoyl-1H-indole and 4-thiazolidinone groups. Monatsh Chem  2020,151(9),1443-1452","journal-title":"Monatsh Chem"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"70","DOI":"10.2174\/1389557511307010070","volume":"13","author":"Shah S.A.S.","year":"2012","unstructured":"Shah S.A.S.; Rivera G.; Ashfaq M.; Recent advances in medicinal chemistry of sulfonamides. Rational design as anti-tumoral, anti-bacterial and anti-inflammatory agents. Mini Rev Med Chem  2012,13(1),70-86","journal-title":"Mini Rev Med Chem"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"133490","DOI":"10.1016\/j.molstruc.2022.133490","volume":"1265","author":"George J.","year":"2022","unstructured":"George J.; Lekha V.S.; G R.N.; Mary Y.S.; Al-Otaibi J.S.; K R.; Synthesis, crystal structure and anti-tumour activity studies of 4- Tertiarybutylcyclohexanonethiosemicarbazone. J Mol Struct  2022,1265,133490","journal-title":"J Mol Struct"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.ccr.2008.07.004","volume":"253","author":"Lobana T.S.","year":"2009","unstructured":"Lobana T.S.; Sharma R.; Bawa G.; Khanna S.; Bonding and structure trends of thiosemicarbazone derivatives of metals\u2014An overview. Coord Chem Rev  2009,253(7-8),977-1055","journal-title":"Coord Chem Rev"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"12645","DOI":"10.3390\/molecules181012645","volume":"18","author":"Reis D.","year":"2013","unstructured":"Reis D.; Despaigne A.; Silva J.; Silva N.; Vilela C.; Mendes I.; Takahashi J.; Beraldo H.; Structural studies and investigation on the activity of imidazole-derived thiosemicarbazones and hydrazones against crop-related fungi. Molecules  2013,18(10),12645-12662","journal-title":"Molecules"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1007\/s00775-015-1292-0","volume":"20","author":"Rogolino D.","year":"2015","unstructured":"Rogolino D.; Bacchi A.; Luca L.; de ; Rispoli G.; Sechi M.; Stevaert A.; Naesens L.; Carcelli M.; Investigation of the salicylaldehyde thiosemicarbazone scaffold for inhibition of influenza virus PA endonuclease. J Biol Inorg Chem  2015,20(7),1109-1121","journal-title":"J Biol Inorg Chem"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.saa.2005.05.001","volume":"63","author":"Suni V.","year":"2006","unstructured":"Suni V.; Prathapachandra Kurup M.R.; Nethaji M.; Structural and spectral perspectives of a novel thiosemicarbazone synthesized from di-2-pyridyl ketone and 4-phenyl-3-thiosemicarbazide. Spectrochim Acta A Mol Biomol Spectrosc  2006,63(1),174-181","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.chroma.2012.08.007","volume":"1269","author":"Carradori S.","year":"2012","unstructured":"Carradori S.; Cirilli R.; Dei Cicchi S.; Ferretti R.; Menta S.; Pierini M.; Secci D.; 3-Methylcyclohexanone thiosemicarbazone: Determination of E\/Z isomerization barrier by dynamic high-performance liquid chromatography, configuration assignment and theoretical study of the mechanisms involved by the spontaneous, acid and base catalyzed processes. J Chromatogr A  2012,1269,168-177","journal-title":"J Chromatogr A"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"127782","DOI":"10.1016\/j.molstruc.2020.127782","volume":"1207","author":"Afonin A.V.","year":"2020","unstructured":"Afonin A.V.; Pavlov D.V.; Albanov A.V.; Mal\u2019kina A.G.; Solvent-induced E\/Z isomerization of 2-(furylmethylidene)-1-hydrazinecarbothioamide: The N\u2013H\u22c5O intramolecular hydrogen bond as promoting factor. J Mol Struct  2020,1207,127782","journal-title":"J Mol Struct"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1080\/17518253.2020.1737252","volume":"13","author":"Ali N.H.S.O.","year":"2020","unstructured":"Ali N.H.S.O.; Hamid M.H.S.A.; Putra N.A.A.M.A.; Adol H.A.; Mirza A.H.; Usman A.; Siddiquee T.A.; Hoq M.R.; Karim M.R.; Efficient eco-friendly syntheses of dithiocarbazates and thiosemicarbazones. Green Chem Lett Rev  2020,13(2),129-140","journal-title":"Green Chem Lett Rev"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"111620","DOI":"10.1016\/j.jinorgbio.2021.111620","volume":"225","author":"Bajaj K.","year":"2021","unstructured":"Bajaj K.; Buchanan R.M.; Grapperhaus C.A.; Antifungal activity of thiosemicarbazones, bis(thiosemicarbazones), and their metal complexes. J Inorg Biochem  2021,225,111620","journal-title":"J Inorg Biochem"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"104202","DOI":"10.1016\/j.bioorg.2020.104202","volume":"104","author":"Sevin\u00e7li Z.\u015e.","year":"2020","unstructured":"Sevin\u00e7li Z.\u015e.; Duran G.N.; \u00d6zbil M.; Karal\u0131 N.; Synthesis, molecular modeling and antiviral activity of novel 5-fluoro-1H-indole-2,3-dione 3-thiosemicarbazones. Bioorg Chem  2020,104,104202","journal-title":"Bioorg Chem"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"105799","DOI":"10.1016\/j.bioorg.2022.105799","volume":"124","author":"Xu Y.S.","year":"2022","unstructured":"Xu Y.S.; Chigan J.Z.; Li J.Q.; Ding H.H.; Sun L.Y.; Liu L.; Hu Z.; Yang K.W.; Hydroxamate and thiosemicarbazone: Two highly promising scaffolds for the development of SARS-CoV-2 antivirals. Bioorg Chem  2022,124,105799","journal-title":"Bioorg Chem"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1080\/14756366.2022.2041629","volume":"37","author":"Ib\u00e1\u00f1ez-Escribano A.","year":"2022","unstructured":"Ib\u00e1\u00f1ez-Escribano A.; Fonseca-Berzal C.; Mart\u00ednez-Montiel M.; \u00c1lvarez-M\u00e1rquez M.; G\u00f3mez-N\u00fa\u00f1ez M.; Lacueva-Arnedo M.; Espinosa-Buitrago T.; Mart\u00edn-P\u00e9rez T.; Escario J.A.; Merino-Montiel P.; Montiel-Smith S.; G\u00f3mez-Barrio A.; L\u00f3pez \u00d3.; Fern\u00e1ndez-Bola\u00f1os J.G.; Thio- and selenosemicarbazones as antiprotozoal agents against Trypanosoma cruzi and Trichomonas vaginalis. J Enzyme Inhib Med Chem  2022,37(1),781-791","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"8976","DOI":"10.1016\/j.bmc.2008.08.050","volume":"16","author":"G\u00fczel \u00d6.","year":"2008","unstructured":"G\u00fczel \u00d6.; Karal\u0131 N.; Salman A.; Synthesis and antituberculosis activity of 5-methyl\/trifluoromethoxy-1H-indole-2,3-dione 3-thiosemicarbazone derivatives. Bioorg Med Chem  2008,16(19),8976-8987","journal-title":"Bioorg Med Chem"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.22334\/jbhost.v6i2.217.s47","volume":"16","author":"Sardari S.","year":"2017","unstructured":"Sardari S.; Feizi S.; Rezayan A.H.; Azerang P.; Shahcheragh S.M.; Ghavami G.; Habibi A.; Synthesis and biological evaluation of thiosemicarbazide derivatives endowed with high activity toward mycobacterium bovis. Iran J Pharm Res  2017,16(3),1128-1140","journal-title":"Iran J Pharm Res"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"176","DOI":"10.26650\/IstanbulJPharm.2020.0086","volume":"50","author":"Sevin\u00e7li Z.\u015e.","year":"2020","unstructured":"Sevin\u00e7li Z.\u015e.; Cant\u00fcrk Z.; Dikmen M.; Karal\u0131 N.L.; Anticancer and antituberculosis effects of 5-fluoro1H-indole-2,3-dione 3-thiosemicarbazones. Istanbul J Pharm  2020,50(3),176-180","journal-title":"Istanbul J Pharm"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"6974","DOI":"10.1016\/j.bmc.2015.09.036","volume":"23","author":"Parker E.N.","year":"2015","unstructured":"Parker E.N.; Song J.; Kishore Kumar G.D.; Odutola S.O.; Chavarria G.E.; Charlton-Sevcik A.K.; Strecker T.E.; Barnes A.L.; Sudhan D.R.; Wittenborn T.R.; Siemann D.W.; Horsman M.R.; Chaplin D.J.; Trawick M.L.; Pinney K.G.; Synthesis and biochemical evaluation of benzoylbenzophenone thiosemicarbazone analogues as potent and selective inhibitors of cathepsin L. Bioorg Med Chem  2015,23(21),6974-6992","journal-title":"Bioorg Med Chem"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"105968","DOI":"10.1016\/j.bioorg.2022.105968","volume":"127","author":"Othman E.M.","year":"2022","unstructured":"Othman E.M.; Fayed E.A.; Husseiny E.M.; Abulkhair H.S.; The effect of novel synthetic semicarbazone- and thiosemicarbazone-linked 1,2,3-triazoles on the apoptotic markers, VEGFR-2, and cell cycle of myeloid leukemia. Bioorg Chem  2022,127,105968","journal-title":"Bioorg Chem"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"130152","DOI":"10.1016\/j.bbagen.2022.130152","volume":"1866","author":"Dharmasivam M.","year":"2022","unstructured":"Dharmasivam M.; Azad M.G.; Afroz R.; Richardson V.; Jansson P.J.; Richardson D.R.; The thiosemicarbazone, DpC, broadly synergizes with multiple anti-cancer therapeutics and demonstrates temperature- and energy-dependent uptake by tumor cells. Biochim Biophys Acta, Gen Subj  2022,1866(8),130152","journal-title":"Biochim Biophys Acta, Gen Subj"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1007\/s00044-020-02503-w","volume":"29","author":"Song J.","year":"2020","unstructured":"Song J.; Pan R.; Li G.; Su W.; Song X.; Li J.; Liu S.; Synthesis and anticancer activities of thiosemicarbazones derivatives of thiochromanones and related scaffolds. Med Chem Res  2020,29(4),630-642","journal-title":"Med Chem Res"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"3714","DOI":"10.1016\/j.bmc.2017.05.029","volume":"25","author":"Karal\u0131 N.","year":"2017","unstructured":"Karal\u0131 N.; Akdemir A.; G\u00f6kta\u015f F.; Eraslan Elma P.; Angeli A.; K\u0131z\u0131l\u0131rmak M.; Supuran C.T.; Novel sulfonamide-containing 2-indolinones that selectively inhibit tumor-associated alpha carbonic anhydrases. Bioorg Med Chem  2017,25(14),3714-3718","journal-title":"Bioorg Med Chem"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"6493","DOI":"10.1039\/C5OB00688K","volume":"13","author":"G\u00fczel-Akdemir \u00d6.","year":"2015","unstructured":"G\u00fczel-Akdemir \u00d6.; Akdemir A.; Karal\u0131 N.; Supuran C.T.; Discovery of novel isatin-based sulfonamides with potent and selective inhibition of the tumor-associated carbonic anhydrase isoforms IX and XII. Org Biomol Chem  2015,13(23),6493-6499","journal-title":"Org Biomol Chem"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.3390\/ijms20092354","volume":"20","author":"Demir-Yaz\u0131c\u0131 K.","year":"2019","unstructured":"Demir-Yaz\u0131c\u0131 K.; Bua S.; Akg\u00fcne\u015f N.M.; Akdemir A.; Supuran C.T.; G\u00fczel-Akdemir \u00d6.; Indole-based hydrazones containing A sulfonamide moiety as selective inhibitors of tumor-associated human carbonic anhydrase isoforms IX and XII. Int J Mol Sci  2019,20(9),2354","journal-title":"Int J Mol Sci"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"5228","DOI":"10.1016\/j.bmc.2013.06.029","volume":"21","author":"Akdemir A.","year":"2013","unstructured":"Akdemir A.; G\u00fczel-Akdemir \u00d6.; Scozzafava A.; Capasso C.; Supuran C.T.; Inhibition of tumor-associated human carbonic anhydrase isozymes IX and XII by a new class of substituted-phenylacetamido aromatic sulfonamides. Bioorg Med Chem  2013,21(17),5228-5232","journal-title":"Bioorg Med Chem"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.bmcl.2007.10.110","volume":"18","author":"G\u00fczel \u00d6.","year":"2008","unstructured":"G\u00fczel \u00d6.; Temperini C.; Innocenti A.; Scozzafava A.; Salman A.; Supuran C.T.; Carbonic anhydrase inhibitors. Interaction of 2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide with 12 mammalian isoforms: Kinetic and X-ray crystallographic studies. Bioorg Med Chem Lett  2008,18(1),152-158","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"9113","DOI":"10.1016\/j.bmc.2008.09.032","volume":"16","author":"G\u00fczel \u00d6.","year":"2008","unstructured":"G\u00fczel \u00d6.; Innocenti A.; Scozzafava A.; Salman A.; Parkkila S.; Hilvo M.; Supuran C.T.; Carbonic anhydrase inhibitors: Synthesis and inhibition studies against mammalian isoforms I\u2013XV with a series of 2-(hydrazinocarbonyl)-3-substituted-phenyl-1H-indole-5-sulfonamides. Bioorg Med Chem  2008,16(20),9113-9120","journal-title":"Bioorg Med Chem"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"2931","DOI":"10.1016\/j.bmcl.2009.04.068","volume":"19","author":"G\u00fczel \u00d6.","year":"2009","unstructured":"G\u00fczel \u00d6.; Maresca A.; Scozzafava A.; Salman A.; Balaban A.T.; Supuran C.T.; Carbonic anhydrase inhibitors. Synthesis of 2,4,6-trimethylpyridinium derivatives of 2-(hydrazinocarbonyl)-3-aryl-1H-indole-5-sulfonamides acting as potent inhibitors of the tumor-associated isoform IX and XII. Bioorg Med Chem Lett  2009,19(11),2931-2934","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.1016\/j.bmcl.2009.04.123","volume":"19","author":"G\u00fczel \u00d6.","year":"2009","unstructured":"G\u00fczel \u00d6.; Innocenti A.; Scozzafava A.; Salman A.; Supuran C.T.; Carbonic anhydrase inhibitors. Phenacetyl-, pyridylacetyl- and thienylacetyl-substituted aromatic sulfonamides act as potent and selective isoform VII inhibitors. Bioorg Med Chem Lett  2009,19(12),3170-3173","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"3317","DOI":"10.2174\/138161210793429805","volume":"16","author":"G\u00fczel O.","year":"2010","unstructured":"G\u00fczel O.; Innocenti A.; Vullo D.; Scozzafava A.; Supuran C.T.; 3-phenyl-1H-indole-5-sulfonamides: Structure-based drug design of a promising class of carbonic anhydrase inhibitors. Curr Pharm Des  2010,16(29),3317-3326","journal-title":"Curr Pharm Des"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1021\/jm101541x","volume":"54","author":"Pacchiano F.","year":"2011","unstructured":"Pacchiano F.; Carta F.; McDonald P.C.; Lou Y.; Vullo D.; Scozzafava A.; Dedhar S.; Supuran C.T.; Ureido-substituted benzenesulfonamides potently inhibit carbonic anhydrase IX and show antimetastatic activity in a model of breast cancer metastasis. J Med Chem  2011,54(6),1896-1902","journal-title":"J Med Chem"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1097\/COC.0000000000000691","volume":"43","author":"McDonald P.C.","year":"2020","unstructured":"McDonald P.C.; Chia S.; Bedard P.L.; Chu Q.; Lyle M.; Tang L.; Singh M.; Zhang Z.; Supuran C.T.; Renouf D.J.; Dedhar S.; A phase 1 study of SLC-0111, a novel inhibitor of carbonic anhydrase IX, in patients with advanced solid tumors. Am J Clin Oncol  2020,43(7),484-490","journal-title":"Am J Clin Oncol"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.ejmech.2018.10.068","volume":"162","author":"Eldehna W.M.","year":"2019","unstructured":"Eldehna W.M.; Abo-Ashour M.F.; Nocentini A.; El-Haggar R.S.; Bua S.; Bonardi A.; Al-Rashood S.T.; Hassan G.S.; Gratteri P.; Abdel-Aziz H.A.; Supuran C.T.; Enhancement of the tail hydrophobic interactions within the carbonic anhydrase IX active site via structural extension: Design and synthesis of novel N-substituted isatins-SLC-0111 hybrids as carbonic anhydrase inhibitors and antitumor agents. Eur J Med Chem  2019,162,147-160","journal-title":"Eur J Med Chem"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13046-022-02345-x","volume":"41","author":"Sarnella A.","year":"2022","unstructured":"Sarnella A.; Ferrara Y.; Auletta L.; Albanese S.; Cerchia L.; Alterio V.; De Simone G.; Supuran C.T.; Zannetti A.; Inhibition of carbonic anhydrases IX\/XII by SLC-0111 boosts cisplatin effects in hampering head and neck squamous carcinoma cell growth and invasion. J Exp Clin Cancer Res  2022,41(1),122","journal-title":"J Exp Clin Cancer Res"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1021\/jm021123s","volume":"46","author":"Ilies M.A.","year":"2003","unstructured":"Ilies M.A.; Vullo D.; Pastorek J.; Scozzafava A.; Ilies M.; Caproiu M.T.; Pastorekova S.; Supuran C.T.; Carbonic anhydrase inhibitors. Inhibition of tumor-associated isozyme IX by halogenosulfanilamide and halogenophenylaminobenzolamide derivatives. J Med Chem  2003,46(11),2187-2196","journal-title":"J Med Chem"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1021\/ja01216a022","volume":"68","author":"McKee R.L.","year":"1946","unstructured":"McKee R.L.; Bost R.W.; para-Substituted phenyl isothiocyanates and some related thioureas. J Am Chem Soc  1946,68(12),2506-2507","journal-title":"J Am Chem Soc"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"3475","DOI":"10.1016\/j.bmcl.2008.05.051","volume":"18","author":"Cecchi A.","year":"2008","unstructured":"Cecchi A.; Ciani L.; Winum J.Y.; Montero J.L.; Scozzafava A.; Ristori S.; Supuran C.T.; Carbonic anhydrase inhibitors: Design of spin-labeled sulfonamides incorporating TEMPO moieties as probes for cytosolic or transmembrane isozymes. Bioorg Med Chem Lett  2008,18(12),3475-3480","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=61","author":"Eraslan Elma P.","year":"2017","unstructured":"Eraslan Elma P.;  1H-indole-2,3-dione 3-thiosemicarbazone derivatives carrying 3-sulfamoylphenyl moiety: Synthesis, structure determination, molecular modeling and biological activity evaluation PhD  2017","journal-title":"1H-indole-2,3-dione 3-thiosemicarbazone derivatives carrying 3-sulfamoylphenyl moiety: Synthesis, structure determination, molecular modeling and biological activity evaluation PhD"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/chir.22408","volume":"27","author":"Ta\u015fdemir D.","year":"2015","unstructured":"Ta\u015fdemir D.; Karak\u00fc\u00e7\u00fck-\u0130yido\u011fan A.; Ula\u015fli M.; Ta\u015fkin-Tok T.; Oru\u00e7-Emre E.E.; Bayram H.; Synthesis, molecular modeling, and biological evaluation of novel chiral thiosemicarbazone derivatives as potent anticancer agents. Chirality  2015,27(2),177-188","journal-title":"Chirality"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"5616","DOI":"10.1016\/j.ejmech.2011.09.031","volume":"46","author":"Karak\u00fc\u00e7\u00fck-\u0130yido\u011fan A.","year":"2011","unstructured":"Karak\u00fc\u00e7\u00fck-\u0130yido\u011fan A.; Ta\u015fdemir D.; Oru\u00e7-Emre E.E.; Balzarini J.; Novel platinum(II) and palladium(II) complexes of thiosemicarbazones derived from 5-substitutedthiophene-2-carboxaldehydes and their antiviral and cytotoxic activities. Eur J Med Chem  2011,46(11),5616-5624","journal-title":"Eur J Med Chem"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1007\/s00216-012-6562-x","volume":"405","author":"Stariat J.","year":"2013","unstructured":"Stariat J.; Kova\u0159\u00edkov\u00e1 P.; Ku\u010dera R.; Klime\u0161 J.; Kalinowski D.S.; Richardson D.R.; Ketola R.A.; Identification of in vitro metabolites of the novel anti-tumor thiosemicarbazone, DpC, using ultra-high performance liquid chromatography\u2013quadrupole-time-of-flight mass spectrometry. Anal Bioanal Chem  2013,405(5),1651-1661","journal-title":"Anal Bioanal Chem"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.molstruc.2017.05.054","volume":"1145","author":"Subhashree G.R.","year":"2017","unstructured":"Subhashree G.R.; Haribabu J.; Saranya S.; Yuvaraj P.; Krishnan A.D.; Karvembu R.; Gayathri D.; In vitro antioxidant, antiinflammatory and in silico molecular docking studies of thiosemicarbazones. J Mol Struct  2017,1145,160-169","journal-title":"J Mol Struct"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.molstruc.2008.09.008","volume":"919","author":"Y\u0131ld\u0131z M.","year":"2009","unstructured":"Y\u0131ld\u0131z M.; \u00dcnver H.; Erdener D.; Kiraz A.; \u0130skeleli N.O.; Synthesis, spectroscopic studies and crystal structure of (E)-2-(2,4-dihydroxybenzylidene)thiosemicarbazone and (E)-2-[(1H-indol-3-yl)methylene]thiosemicarbazone. J Mol Struct  2009,919(1-3),227-234","journal-title":"J Mol Struct"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1155\/2011\/826392","volume":"8","author":"Rana A.","year":"2011","unstructured":"Rana A.; Parekh N.; Dabhi H.; Bhoi D.; Kumari N.; Synthesis, crystal structural characterization and biological properties of thiosemicarbazones of schiff bases derived from 4-acyl-2-pyrazoline-5-one. E-J Chem  2011,8(4),1820-1831","journal-title":"E-J Chem"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/cryst6020017","volume":"6","author":"Anderson B.","year":"2016","unstructured":"Anderson B.; Jasinski J.; Freedman M.; Millikan S.; O\u2019Rourke K.; Smolenski V.; Synthesis, crystal structural investigations, and DFT calculations of novel thiosemicarbazones. Crystals  2016,6(2),17","journal-title":"Crystals"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.poly.2015.12.021","volume":"105","author":"K\u0131l\u0131\u00e7-C\u0131kla I.","year":"2016","unstructured":"K\u0131l\u0131\u00e7-C\u0131kla I.; G\u00fcveli \u015e.; Yavuz M.; Bal-Demirci T.; \u00dclk\u00fcseven B.; 5-Methyl-2-hydroxy-acetophenone-thiosemicarbazone and its nickel(II) complex: Crystallographic, spectroscopic (IR, NMR and UV) and DFT studies. Polyhedron  2016,105,104-114","journal-title":"Polyhedron"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.3390\/cryst12111523","volume":"12","author":"Domaga\u0142a M.","year":"2022","unstructured":"Domaga\u0142a M.; Dubis A.T.; Wojtulewski S.; Zabel M.; Pfitzner A.; Hydrogen bonding in crystals of pyrrol-2-yl chloromethyl ketone derivatives and methyl pyrrole-2-carboxylate. Crystals  2022,12(11),1523","journal-title":"Crystals"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"X35","DOI":"10.2116\/analscix.19.x35","volume":"19","author":"Haramura M.","year":"2003","unstructured":"Haramura M.; Tanaka A.; Akimoto T.; Hirayama N.; Crystal structure of dichlorphenamide. X-ray Struct. Anal Online  2003,19,X35-X36","journal-title":"Anal Online"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.molstruc.2015.02.042","volume":"1089","author":"Ceylan \u00dc.","year":"2015","unstructured":"Ceylan \u00dc.; Durgun M.; T\u00fcrkmen H.; Yal\u00e7\u0131n \u015e.P.; Kilic A.; \u00d6zdemir N.; Theoretical and experimental investigation of 4-[(2-hydroxy-3-methylbenzylidene)amino]benzenesulfonamide: Structural and spectroscopic properties, NBO, NLO and NPA analysis. J Mol Struct  2015,1089,222-232","journal-title":"J Mol Struct"},{"key":"ref=73","first-page":"545","volume":"27","author":"G\u00fcrsoy A.","year":"2003","unstructured":"G\u00fcrsoy A.; Karal\u0131 N.; Synthesis, characterization and primary antituberculosis activity evaluation of 4-(3-coumarinyl)-3-benzyl-4-thiazolin-2-one benzylidenehydrazones. Turk J Chem  2003,27(5),545-552","journal-title":"Turk J Chem"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S0076-6879(97)77018-6","volume":"277","author":"Sheldrick G.M.","year":"1997","unstructured":"Sheldrick G.M.; Schneider T.R.; SHELXL: High-resolution refinement. Methods Enzymol  1997,277,319-343","journal-title":"Methods Enzymol"},{"key":"ref=75","year":"2015","unstructured":"QikProp, 4 Schr\u00f6dinger 2015","journal-title":"QikProp, 4"},{"key":"ref=76","author":"Bank R.P.D.","unstructured":"Bank R.P.D.; RCSB PDB: Homepage.  Available from:  https:\/\/www.rcsb.org\/"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"2201402","DOI":"10.1080\/14756366.2023.2201402","volume":"38","author":"Fantacuzzi M.","year":"2023","unstructured":"Fantacuzzi M.; D\u2019Agostino I.; Carradori S.; Liguori F.; Carta F.; Agamennone M.; Angeli A.; Sannio F.; Docquier J.D.; Capasso C.; Supuran C.T.; Benzenesulfonamide derivatives as Vibrio cholerae carbonic anhydrases inhibitors: A computational-aided insight in the structural rigidity-activity relationships. J Enzyme Inhib Med Chem  2023,38(1),2201402","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"4610","DOI":"10.3390\/molecules27144610","volume":"27","author":"Gumus A.","year":"2022","unstructured":"Gumus A.; Bozdag M.; Akdemir A.; Angeli A.; Selleri S.; Carta F.; Supuran C.T.; Thiosemicarbazide-substituted coumarins as selective inhibitors of the tumor associated human carbonic anhydrases IX and XII. Molecules  2022,27(14),4610","journal-title":"Molecules"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"770","DOI":"10.3390\/v13050770","volume":"13","author":"Senaweera S.","year":"2021","unstructured":"Senaweera S.; Du H.; Zhang H.; Kirby K.A.; Tedbury P.R.; Xie J.; Sarafianos S.G.; Wang Z.; Discovery of new small molecule hits as hepatitis B virus capsid assembly modulators: Structure and pharmacophore-based approaches. Viruses  2021,13(5),770","journal-title":"Viruses"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","volume":"46","author":"Lipinski C.A.","year":"2001","unstructured":"Lipinski C.A.; Lombardo F.; Dominy B.W.; Feeney P.J.; Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3\u201325. 1. Adv Drug Deliv Rev  2001,46(1-3),3-26","journal-title":"Adv Drug Deliv Rev"}],"container-title":["Anti-Cancer Agents in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0118715206290722240125112447","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/226634\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0118715206290722240125112447","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T03:27:49Z","timestamp":1756351669000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/226634\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":80,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0118715206290722240125112447","relation":{},"ISSN":["1871-5206"],"issn-type":[{"value":"1871-5206","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2023-11-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-01-02","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-01-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}